Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-010010
Filing Date
2013-02-15
Accepted
2013-02-15 11:05:08
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 rrd369917.html 5  
1 FORM 5 rrd369917.xml 5 11541
  Complete submission text file 0001181431-13-010010.txt   12891
Mailing Address 2525 28TH STREET SUITE 200 BOULDER CO 80301
Business Address
Allen Andrew R (Reporting) CIK: 0001374539 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35347 | Film No.: 13617965

Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations